Sep 12 |
Biotech Stock Roundup: TERN, SMMT Stocks Surge on Study Data, GSK's Vaccine Study Fails & More
|
Sep 11 |
Terns Pharmaceuticals prices $150M stock offering
|
Sep 11 |
Terns Announces Pricing of Upsized $150.15 Million Public Offering
|
Sep 10 |
Terns Stock Soars on Positive Data From Phase I Study of Obesity Drug
|
Sep 10 |
Terns Pharmaceuticals: Weight Loss Drug TERN-601 Is Competitive
|
Sep 10 |
Terns Pharmaceuticals reports positive data from Phase I trial of obesity treatment
|
Sep 9 |
Terns Pharmaceuticals launches $125M public offering
|
Sep 9 |
Terns Announces Proposed Public Offering
|
Sep 9 |
Terns Pharmaceuticals Stock Is Soaring on Good Data for Weight-Loss Pill
|
Sep 9 |
Terns Pharmaceuticals' Oral GLP-1 Reaches Phase 1 Finish Line With Encouraging Weight Loss Data After One Month
|